We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Biotechnology firm Biocon has received the Establishment Inspection Report (EIR) with ’voluntary action indicated’ status from the US FDA on closure of inspection of its aseptic drug product facility.
Granules India has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility at Visakhapatnam, Andhra Pradesh.